Contribution of hypoxia to Alzheimer’s disease: is HIF-1α a mediator of neurodegeneration? (original) (raw)

• Siesjo BK (1988) Mechanisms of ischemic brain damage. Crit Care Med 16:954–963
  Article CAS PubMed Google Scholar
• Yager JY, Wright S, Armstrong EA, Jahraus CM, Saucier DM (2006) The influence of aging on recovery following ischemic brain damage. Behav Brain Res 173:171–180
  Article PubMed Google Scholar
• Kolb B (2003) Overview of cortical plasticity and recovery from brain injury. Phys Med Rehabil Clin N Am 14:S7–S25
  Google Scholar
• Marini AM, Choi J, Labutta R (2001) Synaptic deprivation and age-related vulnerability to hypoxic–ischemic neuronal injury. A hypothesis. Ann N Y Acad Sci 939:238–253
  CAS PubMed Google Scholar
• Jellinger KA, Attems J (2005) Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci 229–230:37–41
  Article PubMed Google Scholar
• Joseph J, Shukitt-Hale B, Denisova NA, Martin A, Perry G, Smith MA (2001) Copernicus revisited: amyloid beta in Alzheimer’s disease. Neurobiol Aging 22:131–146
  Article CAS PubMed Google Scholar
• Tamaoka A, Sawamura N, Fukushima T, Shoji S, Matsubara E, Shoji M, Hirai S, Furiya Y, Endoh R, Mori H (1997) Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer’s disease. J Neurol Sci 148:41–45
  Article CAS PubMed Google Scholar
• Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB et al (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359:322–325
  Article CAS PubMed Google Scholar
• Steinhilb ML, Dias-Santagata D, Mulkearns EE, Shulman JM, Biernat J, Mandelkow EM, Feany MB (2007) S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. J Neurosci Res 85:1271–1278
  Article CAS PubMed Google Scholar
• Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E (1993) Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett 336:417–424
  Article CAS PubMed Google Scholar
• Galloway PG, Perry G, Gambetti P (1987) Hirano body filaments contain actin and actin-associated proteins. J Neuropathol Exp Neurol 46:185–199
  Article CAS PubMed Google Scholar
• Hirano A (1994) Hirano bodies and related neuronal inclusions. Neuropathol Appl Neurobiol 20:3–11
  Article CAS PubMed Google Scholar
• Anderton BH (2002) Ageing of the brain. Mech Ageing Dev 123:811–817
  Article CAS PubMed Google Scholar
• Mitake S, Ojika K, Hirano A (1997) Hirano bodies and Alzheimer’s disease. Kaohsiung J Med Sci 13:10–18
  CAS PubMed Google Scholar
• Minamide LS, Striegl AM, Boyle JA, Meberg PJ, Bamburg JR (2000) Neurodegenerative stimuli induce persistent ADF/cofilin–actin rods that disrupt distal neurite function. Nat Cell Biol 2:628–636
  Article CAS PubMed Google Scholar
• Coppede F, Mancuso M, Siciliano G, Migliore L, Murri L (2006) Genes and the environment in neurodegeneration. Biosci Rep 26:341–367
  Article CAS PubMed Google Scholar
• Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, Siedlak SL, Vinters HV, Head E, Perry G, Lamanna JC, Friedland RP, Cotman CW (2002) Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann N Y Acad Sci 977:45–64
  Article CAS PubMed Google Scholar
• Baldi I, Lebailly P, Mohammed-Brahim B, Letenneur L, Dartigues JF, Brochard P (2003) Neurodegenerative diseases and exposure to pesticides in the elderly. Am J Epidemiol 157:409–414
  Article PubMed Google Scholar
• Mattson MP (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77:1081–1132
  CAS PubMed Google Scholar
• Desmond DW, Moroney JT, Sano M, Stern Y (2002) Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33:2254–2260
  Article PubMed Google Scholar
• Kalaria RN (2000) The role of cerebral ischemia in Alzheimer’s disease. Neurobiol Aging 21:321–330
  Article CAS PubMed Google Scholar
• Egashira N, Iwasaki K, Ishibashi M, Hatip-Al-Khatib I, Wolozin B, Mishima K, Irie K, Fujiwara M (2002) Hypoxia enhances beta-amyloid-induced apoptosis in rat cultured hippocampal neurons. Jpn J Pharmacol 90:321–327
  Article CAS PubMed Google Scholar
• Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, Staufenbiel M, Huang LE, Song W (2006) Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA 103:18727–18732
  Article CAS PubMed Google Scholar
• Chen GJ, Xu J, Lahousse SA, Caggiano NL, de la Monte SM (2003) Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection. J Alzheimers Dis 5:209–228
  PubMed Google Scholar
• Jendroska K, Hoffmann OM, Patt S (1997) Amyloid beta peptide and precursor protein (APP) in mild and severe brain ischemia. Ann N Y Acad Sci 826:401–405
  Article CAS PubMed Google Scholar
• Shi J, Yang SH, Stubley L, Day AL, Simpkins JW (2000) Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 853:1–4
  Article CAS PubMed Google Scholar
• Hall ED, Oostveen JA, Dunn E, Carter DB (1995) Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp Neurol 135:17–27
  Article CAS PubMed Google Scholar
• LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat Rev Neurosci 3:862–872
  Article CAS PubMed Google Scholar
• Pearson HA, Peers C (2006) Physiological roles for amyloid beta peptides. J Physiol 575:5–10
  Article CAS PubMed Google Scholar
• Webster NJ, Ramsden M, Boyle JP, Pearson HA, Peers C (2006) Amyloid peptides mediate hypoxic increase of L-type Ca2+ channels in central neurones. Neurobiol Aging 27:439–445
  Article CAS PubMed Google Scholar
• Scragg JL, Fearon IM, Boyle JP, Ball SG, Varadi G, Peers C (2005) Alzheimer’s amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels. FASEB J 19:150–152
  CAS PubMed Google Scholar
• Bazan NG, Lukiw WJ (2002) Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J Biol Chem 277:30359–30367
  Article CAS PubMed Google Scholar
• Wenger RH, Gassmann M (1997) Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 378:609–616
  CAS PubMed Google Scholar
• Wang GL, Semenza GL (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90:4304–4308
  Article CAS PubMed Google Scholar
• Soucek T, Cumming R, Dargusch R, Maher P, Schubert D (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39:43–56
  Article CAS PubMed Google Scholar
• Semenza GL (1998) Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 8:588–594
  Article CAS PubMed Google Scholar
• Ratcliffe PJ, O’Rourke JF, Maxwell PH, Pugh CW (1998) Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 201:1153–1162
  CAS PubMed Google Scholar
• Hofer T, Wenger H, Gassmann M (2002) Oxygen sensing, HIF-1alpha stabilization and potential therapeutic strategies. Pflugers Arch 443:503–507
  Article CAS PubMed Google Scholar
• Acker T, Acker H (2004) Cellular oxygen sensing need in CNS function: physiological and pathological implications. J Exp Biol 207:3171–3188
  Article CAS PubMed Google Scholar
• Maxwell PH, Ratcliffe PJ (2002) Oxygen sensors and angiogenesis. Semin Cell Dev Biol 13:29–37
  Article CAS PubMed Google Scholar
• Semenza GL (2001) HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107:1–3
  Article CAS PubMed Google Scholar
• Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG Jr (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464–468
  Article CAS PubMed Google Scholar
• Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ (2001) Targeting of HIF-alpha to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468–472
  Article CAS PubMed Google Scholar
• Schubert D, Chevion M (1995) The role of iron in beta amyloid toxicity. Biochem Biophys Res Commun 216:702–707
  Article CAS PubMed Google Scholar
• Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer’s disease. Lancet 337:1304–1308
  Article CAS PubMed Google Scholar
• Vangeison G, Carr D, Federoff HJ, Rempe DA (2008) The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1 alpha in neurons and astrocytes. J Neurosci 28:1988–1993
  Article CAS PubMed Google Scholar
• Chavez JC, LaManna JC (2003) Hypoxia-inducible factor-1alpha accumulation in the rat brain in response to hypoxia and ischemia is attenuated during aging. Adv Exp Med Biol 510:337–341
  CAS PubMed Google Scholar
• Liu Y, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX (2008) Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett 582:359–364
  Article CAS PubMed Google Scholar
• Chong ZZ, Li F, Maiese K (2005) Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr Neurovasc Res 2:387–399
  Article CAS PubMed Google Scholar
• Brettschneider J, Widl K, Ehrenreich H, Riepe M, Tumani H (2006) Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases. Neurosci Lett 404:347–351
  Article CAS PubMed Google Scholar
• Storkebaum E, Lambrechts D, Carmeliet P (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26:943–954
  Article CAS PubMed Google Scholar
• Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B, Man WY, De Mol M, Wyns S, Manka D, Vermeulen K, Van Den Bosch L, Mertens N, Schmitz C, Robberecht W, Conway EM, Collen D, Moons L, Carmeliet P (2005) Treatment of motor neuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 8:85–92
  Article CAS PubMed Google Scholar
• Del Bo R, Scarlato M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP (2005) Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 57:373–380
  Article CAS PubMed Google Scholar
• Mateo I, Llorca J, Infante J, Rodriguez-Rodriguez E, Sanchez-Quintana C, Sanchez-Juan P, Berciano J, Combarros O (2006) Case–control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer’s disease. Neurosci Lett 401:171–173
  Article CAS PubMed Google Scholar
• Chapuis J, Tian J, Shi J, Bensemain F, Cottel D, Lendon C, Amouyel P, Mann D, Lambert JC (2006) Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer’s disease. Neurobiol Aging 27:1212–1215
  Article CAS PubMed Google Scholar
• Malyshev IY, Wiegant FA, Mashina SY, Torshin VI, Goryacheva AV, Khomenko IP, Kruglov SV, Pokidyshev DA, Popkova EV, Pshennikova MG, Vlasova MA, Zelenina OM, Manukhina EB (2005) Possible use of adaptation to hypoxia in Alzheimer’s disease: a hypothesis. Med Sci Monit 11:HY31–HY38
  CAS PubMed Google Scholar
• Zhang X, Zhou K, Wang R, Cui J, Lipton SA, Liao FF, Xu H, Zhang YW (2007) Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem 282:10873–10880
  Article CAS PubMed Google Scholar
• Wang R, Zhang YW, Zhang X, Liu R, Zhang X, Hong S, Xia K, Xia J, Zhang Z, Xu H (2006) Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia. FASEB J 20:1275–1277
  Article PubMed CAS Google Scholar
• Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 4:233–234
  Article CAS PubMed Google Scholar
• Ohno M, Sametsky EA, Younkin LH, Oakley H, Younkin SG, Citron M, Vassar R, Disterhoft JF (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer’s disease. Neuron 41:27–33
  Article CAS PubMed Google Scholar
• Cui JG, Fraser PE, St George-Hyslop P, Westaway D, Lukiw WJ (2004) Potential roles for presenilin-1 in oxygen sensing and in glial-specific gene expression. Neuroreport 15:2025–2028
  Article CAS PubMed Google Scholar
• Zhang S, Zhang Z, Sandhu G, Ma X, Yang X, Geiger JD, Kong J (2007) Evidence of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity. Brain Res 1138:221–230
  Article CAS PubMed Google Scholar
• Mendoza-Naranjo A, Gonzalez-Billault C, Maccioni RB (2007) Abeta1–42 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases. J Cell Sci 120:279–288
  Article CAS PubMed Google Scholar
• Lippa CF, Hamos JE, Pulaski-Salo D, DeGennaro LJ, Drachman DA (1992) Alzheimer’s disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol Aging 13:405–411
  Article CAS PubMed Google Scholar
• Friedman JE, Chow EJ, Haddad GG (1998) State of actin filaments is changed by anoxia in cultured rat neocortical neurons. Neuroscience 82:421–427
  Article CAS PubMed Google Scholar
• de la Monte SM, Neely TR, Cannon J, Wands JR (2000) Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons. Cell Mol Life Sci 57:1471–1481
  Article Google Scholar
• McGough A, Pope B, Chiu W, Weeds A (1997) Cofilin changes the twist of F-actin: implications for actin filament dynamics and cellular function. J Cell Biol 138:771–781
  Article CAS PubMed Google Scholar
• Maloney MT, Bamburg JR (2007) Cofilin-mediated neurodegeneration in Alzheimer’s disease and other amyloidopathies. Mol Neurobiol 35:21–44
  Article CAS PubMed Google Scholar
• Liu R, Pei JJ, Wang XC, Zhou XW, Tian Q, Winblad B, Wang JZ (2005) Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms. J Neurochem 94:1225–1234
  Article CAS PubMed Google Scholar
• Stys PK, Jiang Q (2002) Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons. Neurosci Lett 328:150–154
  Article CAS PubMed Google Scholar
• Magin TM, Reichelt J, Hatzfeld M (2004) Emerging functions: diseases and animal models reshape our view of the cytoskeleton. Exp Cell Res 301:91–102
  Article CAS PubMed Google Scholar
• Ishiguro K, Shiratsuchi A, Sato S, Omori A, Arioka M, Kobayashi S, Uchida T, Imahori K (1993) Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett 325:167–172
  Article CAS PubMed Google Scholar
• Hosoi T, Uchiyama M, Okumura E, Saito T, Ishiguro K, Uchida T, Okuyama A, Kishimoto T, Hisanaga S (1995) Evidence for cdk5 as a major activity phosphorylating tau protein in porcine brain extract. J Biochem 117:741–749
  CAS PubMed Google Scholar
• Cheung ZH, Ip NY (2004) Cdk5: mediator of neuronal death and survival. Neurosci Lett 361:47–51
  Article CAS PubMed Google Scholar
• Dhavan R, Tsai LH (2001) A decade of CDK5. Nat Rev Mol Cell Biol 2:749–759
  Article CAS PubMed Google Scholar
• Liu X, Van Vleet T, Schnellmann RG (2004) The role of calpain in oncotic cell death. Annu Rev Pharmacol Toxicol 44:349–370
  Article CAS PubMed Google Scholar
• Ahlijanian MK, Barrezueta NX, Williams RD, Jakowski A, Kowsz KP, McCarthy S, Coskran T, Carlo A, Seymour PA, Burkhardt JE, Nelson RB, McNeish JD (2000) Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci USA 97:2910–2915
  Article CAS PubMed Google Scholar
• Pei JJ, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B, Cowburn RF (1998) Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer’s disease neurofibrillary degeneration. Brain Res 797:267–277
  Article CAS PubMed Google Scholar
• Van den Haute C, Spittaels K, Van Dorpe J, Lasrado R, Vandezande K, Laenen I, Geerts H, Van Leuven F (2001) Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice. Neurobiol Dis 8:32–44
  Article PubMed CAS Google Scholar
• Li BS, Zhang L, Takahashi S, Ma W, Jaffe H, Kulkarni AB, Pant HC (2002) Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J 21:324–333
  Article CAS PubMed Google Scholar
• O’Hare MJ, Kushwaha N, Zhang Y, Aleyasin H, Callaghan SM, Slack RS, Albert PR, Vincent I, Park DS (2005) Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J Neurosci 25:8954–8966
  Article PubMed CAS Google Scholar
• Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360–364
  Article CAS PubMed Google Scholar
• Ma E, Haddad G (1999) A Drosophila CDK5alpha-like molecule and its possible role in response to O(2) deprivation. Biochem Biophys Res Commun 261:459–463
  Article CAS PubMed Google Scholar
• Hayashi T, Warita H, Abe K, Itoyama Y (1999) Expression of cyclin-dependent kinase 5 and its activator p35 in rat brain after middle cerebral artery occlusion. Neurosci Lett 265:37–40
  Article CAS PubMed Google Scholar
• Mitsios N, Pennucci R, Krupinski J, Sanfeliu C, Gaffney J, Kumar P, Kumar S, Juan-Babot O, Slevin M (2007) Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke. Brain Pathol 17:11–23
  Article CAS PubMed Google Scholar
• Rashidian J, Iyirhiaro G, Aleyasin H, Rios M, Vincent I, Callaghan S, Bland RJ, Slack RS, During MJ, Park DS (2005) Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. Proc Natl Acad Sci USA 102:14080–14085
  Article CAS PubMed Google Scholar
• Strocchi P, Pession A, Dozza B (2003) Up-regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR-32 cells. J Cell Biochem 88:758–765
  Article CAS PubMed Google Scholar
• Wu DC, Yu YP, Lee NT, Yu AC, Wang JH, Han YF (2000) The expression of Cdk5, p35, p39, and Cdk5 kinase activity in developing, adult, and aged rat brains. Neurochem Res 25:923–929
  Article CAS PubMed Google Scholar
• Tamada Y, Nakajima E, Nakajima T, Shearer TR, Azuma M (2005) Proteolysis of neuronal cytoskeletal proteins by calpain contributes to rat retinal cell death induced by hypoxia. Brain Res 1050:148–155
  Article CAS PubMed Google Scholar
• Vartiainen N, Keksa-Goldsteine V, Goldsteins G, Koistinaho J (2002) Aspirin provides cyclin-dependent kinase 5-dependent protection against subsequent hypoxia/reoxygenation damage in culture. J Neurochem 82:329–335
  Article CAS PubMed Google Scholar